All articles by Manish Kumar
Manish Kumar
UK’s University of Exeter develops new method for early cancer detection
Royal Devon University Healthcare NHS Trust is the first to integrate the new blood test algorithm for routine analysis to help detect early cancer signs
CergenX gains FDA breakthrough status for neonatal brain injury tech
The AI-powered Wave device analyses newborn EEG data to detect brain injury and enhance real-time neurological health assessment
SurGenTec’s OsteoFlo HydroFiber receives FDA clearance for spine surgery
OsteoFlo HydroFiber is approved as a stand-alone, autograft-equivalent solution for spine surgeries, including interbody fusion cages, disc spaces, and posterolateral fusions
FDA grants breakthrough device status to PreludeDx’s DCISionRT test
DCISionRT offers personalised risk assessment and predicts radiation therapy benefits for women with Stage 0 breast cancer to improve treatment decisions
Neogen launches new MDA2 quantitative salmonella molecular detection assay
The Neogen MDA2QSAL96 kit integrates qualitative pathogen testing solutions and Quantitative Rapid Enrichment Dehydrated (QRED) media
Core Sound Imaging, provider of medical imaging platform studycast, announces $80m growth investment from PSG
Investment to help drive expansion to support platform growth
Sinaptica starts co-development of SinaptiStim Neuromodulation System
The non-invasive neuromodulation therapy, using personalised rTMS to target the Default Mode Network, has received FDA breakthrough device designation for treating Alzheimer’s disease
Johnson & Johnson files NDA with FDA for TAR-200 drug releasing system
TAR-200 is an investigational system for sustained gemcitabine delivery into the bladder, placed in under five minutes without anaesthesia in an outpatient setting
BD boosts US manufacturing of critical medical devices
One line is already fully operational with additional lines expected to start up in the coming months
Owlstone Medical announces $27m first close in series E financing round
Funding will be used to accelerate commercialization and further clinical trials of Breath Biopsy diagnostic tests and point of care devices for lung cancer, liver disease, and digestive disease